Published in Am J Pathol on November 01, 2000
Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol (2008) 2.93
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer (2003) 2.90
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol (2005) 2.74
Deciphering and reversing tumor immune suppression. Immunity (2013) 2.24
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci U S A (2003) 2.23
Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A (2001) 1.47
Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol (2000) 1.44
Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest (2003) 1.43
Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2013) 1.40
Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol (2005) 1.29
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther (2007) 1.23
Endothelin-1: a multifunctional molecule in cancer. Br J Cancer (2003) 1.23
Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J Physiol (2004) 1.14
Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol (2010) 1.13
Endothelin receptors as novel targets in tumor therapy. J Transl Med (2004) 1.07
Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res (2009) 1.05
Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol (2004) 1.04
Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells. PLoS One (2012) 1.04
Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells. Cancer Biol Ther (2012) 1.04
Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in human skeletal muscle interstitium. J Physiol (2003) 1.02
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. J Transl Med (2013) 0.99
Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo. BMC Complement Altern Med (2012) 0.98
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS One (2010) 0.98
Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med (2008) 0.96
Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. Angiogenesis (2011) 0.95
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice. Clin Cancer Res (2015) 0.94
Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol (2009) 0.92
Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol (2015) 0.89
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. J Cell Biochem (2008) 0.89
The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. Carcinogenesis (2014) 0.88
Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am J Pathol (2003) 0.88
Nicotine and pathological angiogenesis. Life Sci (2012) 0.87
Endothelin-1 as a target for therapeutic intervention in prostate cancer. Invest New Drugs (2002) 0.86
Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. Am J Pathol (2001) 0.86
EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. Oncotarget (2014) 0.85
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol (2003) 0.85
Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol (2008) 0.85
Factors associated with changes in endothelin-1 gene expression in patients with diabetic retinopathy in type 2 diabetes mellitus. Mol Vis (2010) 0.84
Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res (2012) 0.84
Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model. Stem Cells Transl Med (2014) 0.83
Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases. Clin Exp Nephrol (2014) 0.82
Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2013) 0.81
The Ras activator RasGRP3 mediates diabetes-induced embryonic defects and affects endothelial cell migration. Circ Res (2011) 0.81
Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells. Diabetes (2016) 0.81
Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor. MAbs (2012) 0.81
ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer. Expert Opin Investig Drugs (2008) 0.81
Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma. BMC Cancer (2008) 0.81
Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy. Curr Bioact Compd (2010) 0.80
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma. Oncotarget (2016) 0.80
The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways. J Transl Med (2013) 0.80
Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer (2013) 0.79
Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B. World J Gastroenterol (2007) 0.79
Three-dimensional 10% cyclic strain reduces bovine aortic endothelial cell angiogenic sprout length and augments tubulogenesis in tubular fibrin hydrogels. J Tissue Eng Regen Med (2010) 0.79
Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy. Am J Pathol (2014) 0.78
Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome. Am J Pathol (2014) 0.78
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression. Oncotarget (2016) 0.78
Comparison of upstream regulators in human ex vivo cultured cornea limbal epithelial stem cells and differentiated corneal epithelial cells. BMC Genomics (2013) 0.78
Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults. Diabetol Metab Syndr (2015) 0.78
OCT4 Remodels the Phenotype and Promotes Angiogenesis of HUVECs by Changing the Gene Expression Profile. Int J Med Sci (2016) 0.77
PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation. J Cell Mol Med (2014) 0.77
Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One (2013) 0.77
Down but not out: an emerging role for the B-type endothelin receptor in placental ischemia-induced hypertension. Hypertension (2014) 0.76
Endothelial cells enhance the migration of bovine meniscus cells. Arthritis Rheumatol (2015) 0.76
Control of the adaptive immune response by tumor vasculature. Front Oncol (2014) 0.76
Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells (2015) 0.76
Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma. Cancer Biol Ther (2016) 0.76
Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse? Cancer Biol Ther (2010) 0.75
G-231A and G+70C Polymorphisms of Endothelin Receptor Type-A Gene could Affect the Psoriasis Area and Severity Index Score and Endothelin 1 Levels. Indian J Dermatol (2015) 0.75
Inflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosis. Mol Med Rep (2015) 0.75
Targeting brain microvascular endothelial cells: a therapeutic approach to neuroprotection against stroke. Neural Regen Res (2015) 0.75
[Angiogenesis. Possibilities for therapeutic intervention in rheumatic diseases]. Z Rheumatol (2007) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
Angiogenesis. J Biol Chem (1992) 11.29
A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res (1987) 7.43
Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol (1988) 4.33
A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest (1992) 4.21
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev (1994) 4.19
Biology and biochemistry of proteinases in tumor invasion. Physiol Rev (1993) 4.17
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest (1991) 3.18
Peptide growth factors are multifunctional. Nature (1988) 2.71
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol (1990) 2.69
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Endothelins. N Engl J Med (1995) 2.52
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood (1999) 2.30
Mechanisms of angiogenesis. Annu Rev Physiol (1987) 1.68
Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer (1998) 1.48
Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res (1999) 1.46
Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol (2000) 1.44
Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int (1995) 1.38
An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Natl Acad Sci U S A (1999) 1.37
Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res (1997) 1.34
Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem (1997) 1.34
Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension (1997) 1.31
Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. J Cell Physiol (1991) 1.23
Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem (1997) 1.23
Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg (1998) 1.10
Endothelins as autocrine regulators of tumor cell growth. Trends Endocrinol Metab (1998) 1.10
Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol (1997) 1.08
Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem (1994) 1.08
Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int (1993) 1.06
Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res (1995) 1.05
Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol (1999) 1.04
Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Hypertension (1998) 1.02
Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J (1997) 1.01
Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl) (1995) 1.00
Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol (1995) 0.99
Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein. FEBS Lett (1992) 0.97
Angiogenesis in cancer: the role of endothelin-1. Ann R Coll Surg Engl (1999) 0.96
Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. J Cell Sci (1999) 0.94
Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells. Life Sci (1998) 0.90
Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol (1996) 0.87
Localization and characterization of endothelin-1 receptor binding in the blood vessels of human pulmonary tumors. J Cardiovasc Pharmacol (1995) 0.87
Endothelin-1 stimulates its own synthesis in human endothelial cells. Biochem Biophys Res Commun (1992) 0.86
Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Biochem Biophys Res Commun (1993) 0.83
Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc Res (1995) 0.83
Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology. J Cardiovasc Pharmacol (1998) 0.79
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol (1990) 2.69
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res (1986) 2.30
The combination of yondelis and cisplatin is synergistic against human tumor xenografts. Eur J Cancer (2003) 1.63
Role of laminin receptor in tumor cell migration. Cancer Res (1987) 1.58
Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Commun (1990) 1.48
Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res (1986) 1.47
Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res (1999) 1.46
Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol (2000) 1.44
Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst (1986) 1.38
Functional domains of the 67-kDa laminin receptor precursor. J Biol Chem (1991) 1.35
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer (1994) 1.34
Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res (1997) 1.34
Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer (1980) 1.29
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res (2001) 1.29
Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. Clin Cancer Res (1998) 1.21
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther (1995) 1.20
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science (1991) 1.19
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer (2003) 1.18
Outbreaks of hyperkeratotic dermatitis of athymic nude mice in northern Italy. Lab Anim (1997) 1.16
Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest (1988) 1.14
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst (1995) 1.13
Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res (2000) 1.13
The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J (2000) 1.12
β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Oncogene (2012) 1.10
Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol (1995) 1.10
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration. Nature (1987) 1.08
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent. Eur J Cancer Clin Oncol (1987) 1.08
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol (1987) 1.08
The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ (1997) 1.07
Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int J Cancer (1989) 1.05
Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res (1995) 1.05
Whole-genome scan for quantitative trait loci associated with birth weight, gestation length and passive immune transfer in a Holstein x Jersey crossbred population. Anim Genet (2008) 1.04
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol (1998) 1.02
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene (2001) 1.02
Mononuclear phagocyte adherence in the presence of laminin. A possible marker of cellular differentiation. Exp Cell Res (1983) 1.01
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther (1993) 1.01
Increased tumorigenicity and invasiveness of C6 rat glioma cells transfected with the human alpha-2,8 sialyltransferase cDNA. Invasion Metastasis (2000) 1.01
Modelling approaches for angiogenesis. Eur J Cancer (2004) 1.01
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer (1985) 1.01
Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest (1992) 0.99
Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X. Heart (2009) 0.99
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol (1997) 0.99
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Clin Cancer Res (1999) 0.99
Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure. Cancer Res (1989) 0.97
Antiangiogenic activity of aplidine, a new agent of marine origin. Br J Cancer (2004) 0.97
Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst (1989) 0.96
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer. Ann Oncol (1999) 0.95
Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. J Pathol (1999) 0.94
Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line. Cancer Res (1983) 0.94
Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int J Cancer (1989) 0.94
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest (1993) 0.94
Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin. Lab Invest (1998) 0.94
Natural cytotoxic activity in human lungs. Clin Exp Immunol (1982) 0.93
Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res (1993) 0.93
Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells. Exp Cell Res (2000) 0.93
Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur J Cancer (1996) 0.93
Growth and metastatic behavior of human tumor cells implanted into nude and beige nude mice. Clin Exp Metastasis (1987) 0.92
Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis (1993) 0.92
Mesothelial cells induce the motility of human ovarian carcinoma cells. Int J Cancer (1999) 0.91
IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. Int J Cancer (1996) 0.90
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. Br J Cancer (2007) 0.90
Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy. FASEB J (2000) 0.90
Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte-colony-stimulating factor. J Cell Physiol (1993) 0.90
Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J Natl Cancer Inst (1993) 0.89
Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst (1991) 0.89
Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol (1998) 0.88
Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res (1996) 0.88
Shedding of membrane vesicles by tumor and endothelial cells. Ital J Anat Embryol (2005) 0.88
Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int J Cancer (1980) 0.88
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. Cancer Res (1995) 0.88
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents. Clin Cancer Res (2001) 0.88
Distribution of mono-, di, and tri-O-acetylated sialic acids in normal and neoplastic colon. Cancer Res (1988) 0.87
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells. Clin Exp Metastasis (1999) 0.86
Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium. Cancer Res (1991) 0.86
Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. Am J Pathol (2001) 0.86